LYTIR

Insider · SEC Form 4 · Chief Medical Officer

Mollie Leoni

Filed with the SEC as Leoni Mollie; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.3M of KURA. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.3M in total.Jun: Insider sales $834KSep: Insider sales $440KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. KURASold: Kura Oncology, Inc. Sep 29, 2026 28,802 shares filed Sep 29, 2026 141,095 shares held directly after, as filed 10b5-1 plan filing $310K
  2. KURASold: Kura Oncology, Inc. Sep 28, 2026 12,448 shares filed Sep 29, 2026 169,897 shares held directly after, as filed filing $131K
  3. KURASold: Kura Oncology, Inc. Jun 18, 2026 84,929 shares filed Jun 22, 2026 182,345 shares held directly after, as filed 10b5-1 plan filing $834K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.